[Federal Register Volume 88, Number 35 (Wednesday, February 22, 2023)]
[Notices]
[Pages 10904-10905]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03568]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--DP23-001, Panel A, Assessing the Effectiveness of 
Programs, Policies, or Practices That Affect Social Determinants of 
Health To Promote Health Equity and Reduce Health Disparities in 
Chronic Diseases; Amended Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--DP23-001, Panel A, Assessing the Effectiveness of Programs, 
Policies, or Practices that Affect Social Determinants of Health to 
Promote Health Equity and Reduce Health Disparities in Chronic 
Diseases; April 18, 2023, 10 a.m.-6 p.m., EDT, teleconference, in the 
original Federal Register notice. The meeting was published in the 
Federal Register on February 9, 2023, Volume 88, Number 27, page 8431.

[[Page 10905]]

    The meeting is being amended to change the meeting date and should 
read as follows:

Date: April 21, 2023.
Time: 10 a.m.-6 p.m., EDT.

    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Natalie Brown, M.P.H., Scientific 
Review Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 4770 Buford Highway, Mailstop S107-8, Atlanta, 
Georgia 30341-3717; Telephone: (404) 639-4601; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-03568 Filed 2-21-23; 8:45 am]
BILLING CODE 4163-18-P